Belzutifan+pembrolizumab post-surgery helps kidney cancer patients at high risk for relapse stay cancer-free longer

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEY…

KEY + WEL as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death Compared to KEYTRUDA Mono in Certain Patients ...
Hosted on MSN

Kidney cancer warning: Fifth of patients do not receive diagnosis until it's too late

The UK's leading kidney cancer charity has warned that 'highly restrictive' health guidelines mean a fifth of patients are getting diagnosed at the most advanced stage of the disease. New data from ...
Cure Today

A Patients Navigation Guide to Stage 2 Clear Cell Renal Cell Carcinoma

Stage 2 ccRCC is localized, with tumors larger than 7 cm but no lymph node or distant metastasis involvement. Diagnosis involves imaging, laboratory tests, and occasionally biopsy, with surgery as the ...